Cargando…

Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review

BACKGROUND: Rapid molecular diagnostics for detecting multidrug-resistant and extensively drug-resistant tuberculosis (M/XDR-TB) primarily identify mutations in Mycobacterium tuberculosis (Mtb) genes associated with drug resistance. Their accuracy, however, is dependent largely on the strength of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georghiou, Sophia B., Magana, Marisa, Garfein, Richard S., Catanzaro, Donald G., Catanzaro, Antonino, Rodwell, Timothy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315572/ https://www.ncbi.nlm.nih.gov/pubmed/22479378 http://dx.doi.org/10.1371/journal.pone.0033275

Ejemplares similares

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
por: Seifert, Marva, et al.
Publicado: (2015)

Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand
por: Sowajassatakul, Angkanang, et al.
Publicado: (2014)

Rapid Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol Using Genotype MTBDRsl Assay: A Meta-Analysis
por: Feng, Yan, et al.
Publicado: (2013)

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
por: Georghiou, Sophia B., et al.
Publicado: (2016)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

Draft Genome Sequence of Amikacin- and Kanamycin-Resistant Mycobacterium tuberculosis MT433 without rrs and eis Mutations
por: Sowajassatakul, Angkanang, et al.
Publicado: (2015)

Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain
por: Sowajassatakul, Angkanang, et al.
Publicado: (2018)

Correlation between phenotypic and genotypic drug resistance to kanamycin and amikacin in clinical isolates of Mycobacterium tuberculosis
por: Ahmadi, Azam, et al.
Publicado: (2020)

Assessment of Amikacin- and Capreomycin-Related Adverse Drug Reactions in Patients with Multidrug-Resistant Tuberculosis and Exploring the Role of Genetic Factors
por: Freimane, Lauma, et al.
Publicado: (2023)

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis
por: Catanzaro, Antonino, et al.
Publicado: (2015)

Cost analysis of rapid diagnostics for drug-resistant tuberculosis
por: Groessl, Erik J., et al.
Publicado: (2018)

Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease
por: Seifert, Marva, et al.
Publicado: (2021)

A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis
por: Ramirez-Busby, S. M., et al.
Publicado: (2017)

Viability of Human Melanocytes HEMa-LP Exposed to Amikacin and Kanamycin
por: Wrześniok, D., et al.
Publicado: (2013)

1539. A Nine-Gene Blood-Based Signature Meets the World Health Organization Target Product Profiles for Diagnosis of Active Tuberculosis and Predicting Progression from Latent to Active Disease
por: Gupta, Sanjana, et al.
Publicado: (2022)

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis
por: Hillery, Naomi, et al.
Publicado: (2014)

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study
por: Colman, Rebecca E., et al.
Publicado: (2016)

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing
por: Colman, Rebecca E., et al.
Publicado: (2015)

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort
por: Sagwa, Evans L., et al.
Publicado: (2015)

Capreomycin is active against non-replicating M. tuberculosis
por: Heifets, Leonid, et al.
Publicado: (2005)

Capreomycin-induced optic neuritis in a case of multidrug resistant pulmonary tuberculosis
por: Magazine, Rahul, et al.
Publicado: (2010)

Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study
por: Hillery, Naomi, et al.
Publicado: (2021)

Individual pK(a) Values of Tobramycin, Kanamycin B, Amikacin, Sisomicin, and Netilmicin Determined by Multinuclear NMR Spectroscopy
por: Alkhzem, Abdulaziz H., et al.
Publicado: (2020)

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
por: Torres, Jessica N, et al.
Publicado: (2015)

Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
por: Pan, Sheng-Wei, et al.
Publicado: (2023)

The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome
por: Stanley, Robin E., et al.
Publicado: (2010)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Comparison of Serum Potassium, MagnEsium, and Calcium Levels between Kanamycin and Capreomycin-BASEd Regimen-Treated MultiDrug-Resistant TuBerculosis Patients in Bandung (CEASE MDR-TB): A Retrospective Cohort Study
por: Soeroto, Arto Yuwono, et al.
Publicado: (2019)

Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system
por: Colman, Rebecca E., et al.
Publicado: (2022)

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation
por: Colman, Rebecca E., et al.
Publicado: (2019)

Kanamycin and Ofloxacin Activate the Intrinsic Resistance to Multiple Antibiotics in Mycobacterium smegmatis
por: Vatlin, Aleksey A., et al.
Publicado: (2023)

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis
por: Sharma, Vishal, et al.
Publicado: (2016)

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
por: Shao, Zitong, et al.
Publicado: (2023)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin
por: Sukati, Suriyan, et al.
Publicado: (2022)

Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides
por: Man, DeDe Kwun-Wai, et al.
Publicado: (2018)

Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis
por: Bentley, Tanya GK, et al.
Publicado: (2012)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Tuberculosis from Mycobacterium bovis in Binational Communities, United States
por: Rodwell, Timothy C., et al.
Publicado: (2008)

A survey of health professions students for knowledge, attitudes, and confidence about tuberculosis, 2005
por: Jackson, Marguerite, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5mv7vbm53m35le4cn8drl32pda